ANGEL Biotechnology in Pentlands Science Park, Scotland, Inks JV with Russia’s Materia Medica

Joint venture boost for biotech Angel

by Mark Smith deputy business editor

18 Oct 2011

ANGEL Biotechnology, the bio-manufacturing and consulting company which has its headquarters in Edinburgh, yesterday said it had struck a joint venture agreement with its long-time Russian pharmaceutical customer Materia Medica.

Shares in AIM-listed Angel, which operates from the Pentlands Science Park, surged 23.9% to 0.285p on the news.

For full article in Herald Scotland Click Here.

Leave a Reply

You must be logged in to post a comment.